日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.

MILES队列分析揭示了淋巴管肌瘤病疾病进展和治疗反应的决定因素

Gupta Nishant, Lee Hye-Seung, Young Lisa R, Strange Charlie, Moss Joel, Singer Lianne G, Nakata Koh, Barker Alan F, Chapman Jeffrey T, Brantly Mark L, Stocks James M, Brown Kevin K, Lynch Joseph P 3rd, Goldberg Hilary J, Downey Gregory P, Taveira-DaSilva Angelo M, Krischer Jeffrey P, Setchell Kenneth, Trapnell Bruce C, Inoue Yoshikazu, McCormack Francis X

The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult

成人α1-抗胰蛋白酶缺乏症的诊断和治疗

Sandhaus, Robert A; Turino, Gerard; Brantly, Mark L; Campos, Michael; Cross, Carroll E; Goodman, Kenneth; Hogarth, D Kyle; Knight, Shandra L; Stocks, James M; Stoller, James K; Strange, Charlie; Teckman, Jeffrey

Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.

血清 VEGF-D 浓度作为淋巴管肌瘤病严重程度和治疗反应的生物标志物:西罗莫司治疗淋巴管肌瘤病多中心国际疗效 (MILES) 试验的前瞻性分析

Young Lisa, Lee Hye-Seung, Inoue Yoshikazu, Moss Joel, Singer Lianne G, Strange Charlie, Nakata Koh, Barker Alan F, Chapman Jeffrey T, Brantly Mark L, Stocks James M, Brown Kevin K, Lynch Joseph P 3rd, Goldberg Hilary J, Downey Gregory P, Swigris Jeffrey J, Taveira-DaSilva Angelo M, Krischer Jeffrey P, Trapnell Bruce C, McCormack Francis X

IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.

IL10 多态性与严重 α1-抗胰蛋白酶缺乏症的气流阻塞有关

Demeo Dawn L, Campbell Edward J, Barker Alan F, Brantly Mark L, Eden Edward, McElvaney N Gerard, Rennard Stephen I, Sandhaus Robert A, Stocks James M, Stoller James K, Strange Charlie, Turino Gerard, Silverman Edwin K